The Acute Effects of Nifedipine on Calf and Forefoot Blood Flow in Patients with Peripheral Arterial Insufficiency

Abstract

The calcium-blocking agent nifedipine, which possesses vasodilating po tency, was tested in 8 patients with peripheral arterial insufficiency. 10 mg sublingually significantly decreased systolic arm and ankle blood pressure. Neither blood flow nor local peripheral resistance in the calf and the forefoot at rest and the calf during postischemic reactive hyperemia changed significantly. During postischemic hyperemia in the forefoot, the drug significantly reduced peak blood flow and increased local peripheral resistance. The drug-induced reduction in forefoot peak blood flow was correlated to the fall in systolic arm and ankle blood pressure. It is suggested that nifedipine may shorten the claudication distance in patients with peripheral arterial insufficiency.

Get full access to this article

View all access options for this article.

References

Ebner F. , Dunschede HB : Haemodynamics, therapeutic mechanism of action and clinical findings of Adalat use based on world-wide clinical trials. In: 3rd International Adalat Symposium, ed. by A Domingos Jatene and PR Lichtlen, Amsterdam-Oxford, Excerpta Medica , 1976, p. 283.

Guazzi M. , Olivari MT , Polese A. , et al: Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22:528, 1977.

Olivari MT , Bartorelli C. , Polese A. , et al: Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circ 59:1056, 1979.

Lichtlen PR : Regional myocardial blood flow in patients with coronary artery disease after nifedipine. In: International Adalat Panel Discussion. New Experimental and Clinical Results, ed. by PR Lichtlen, E Kimura and N Taira , Amsterdam-Oxford- Princeton, Excerpta Medica, 1979 , p. 69.

Lichtlen PR , Engel H-J. , Wolf R. , et al: The effects of the calcium-antagonistic drug nifedipine on coronary and left ventricular dynamics in patients with coronary heart disease. In: Calcium-Antagonismus, ed. by A Fleckenstein and H Roskamm , Berlin-Heidelberg- New York, Springer-Verlag, 1980 , p. 270.

Aoki K. , Kondo S. , Mochizuki A. , et al: Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade . Am Heart J 96:218, 1978.

Lederballe Pedersen O , Mikkelsen E. : Acute and chronic effects of nifedipine in arterial hypertension. Eur J Clin Pharmacol 14:375, 1978.

Ueda K. , Kuwajima I. , Ito H. , et al: Nifedipine in the management of hypertension. In: International Adalat Panel Discussion. New Experimental and Clinical Results , ed. by PR Lichtlen, E Kimura and N Taira , Amsterdam- Oxford-Princeton, Excerpta Medica , 1979, p. 105.

Mostbeck A. , Partsch H. , Peschl L. : Extracardial effects of nifedipine (Adalat): Measurements of liver blood flow in animals and humans and of peripheral circulation in the lower limbs. In: 2nd International Adalat Symposium, ed. by W Lochner , W Braasch and G Kroneberg , Berlin- Heidelberg-New York , Springer-Verlag , 1975, p. 303.

10.

Thulesius O. , Lim BH , Gjøres JE : Perifera vaskulära effekter av verapamil hos homo. In: Arytmisymposium-Isoptin , ed. by J-H Atterhøg , A Haakana and B Nordling , Gøteborg, Meda Aktiebolag, 1973, p. 47.

11.

Hansteen V. , Lorentsen E. : Vasodilator drugs in the treatment of peripheral arterial insufficiency. Acta Med Scand suppl 556, 1974.

12.

Ekelund L-G. , Orø, L. : Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study. Clin Cardiol 2:203, 1979.

13.

Zetterquist S. : Muscle and skin clearance of antipyrine from exercising ischemic legs before and after vasodilating trials. Acta Med Scand 183:487, 1968.